Weill David

Insider profile

Performance

Overall performance
3.0

Performance over holding periods
4.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 46% 68% 82%
Transactions
9 11% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 109%
Success rate 73%
Average holding period 220
Transactions 28
Weill David's trades of Transmedics Group Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-06 2026-03-04 S Sale
89,958 -30.1%
479.41
US$1,722,623
89,958 -30.1% 479.41 US$1,722,623
2026-03-04 2026-03-04 PrS Proposed sale
94,198
281.06
US$3,471,487
94,198 281.06 US$3,471,487
2025-12-05 2025-12-03 S Sale
72,673 -1.7%
79.31
US$553,812
72,673 -1.7% 79.31 US$553,812
2025-12-03 2025-12-03 PrS Proposed sale
5,000
138.64
US$693,210
5,000 138.64 US$693,210
2025-05-23 2025-05-23 PrS Proposed sale
732
123.88
US$90,683
732 123.88 US$90,683
2025-05-23 2025-05-23 S Sale
732 -5.7%
123.88
US$90,680
732 -5.7% 123.88 US$90,680
2024-05-31 2024-05-29 S Sale
1,193 -10.0%
141.65
US$168,988
1,193 -10.0% 141.65 US$168,988
2024-05-29 2024-05-29 PrS Proposed sale
1,193
141.65
US$168,982
1,193 141.65 US$168,982
2024-05-14 2024-05-10 S Sale
2,500 -18.3%
129.82
US$324,550
2,500 -18.3% 129.82 US$324,550
2024-05-10 2024-05-10 PrS Proposed sale
2,500
130.70
US$326,750
2,500 130.70 US$326,750
2023-08-30 2023-08-29 B Purchase
2,500 +22.3%
62.00
US$155,000
2,500 +22.3% 62.00 US$155,000
2023-02-28 2023-02-27 S Sale
4,970 -33.2%
76.51
US$380,255
4,970 -33.2% 76.51 US$380,255
2023-02-28 2023-02-27 S Sale
964 -6.0%
77.64
US$74,845
964 -6.0% 77.64 US$74,845
2022-11-14 2022-11-10 S Sale
21,645 -61.6%
56.00
US$1,212,120
21,645 -61.6% 56.00 US$1,212,120